Predicting new indications for approved drugs using a proteochemometric method. [electronic resource]
Producer: 20121105Description: 6832-48 p. digitalISSN:- 1520-4804
- Animals
- Antineoplastic Agents -- chemistry
- Antirheumatic Agents -- chemistry
- Cadherins -- metabolism
- Celecoxib
- Cell Line, Tumor
- Crystallography, X-Ray
- Databases, Factual
- Drug Discovery -- methods
- Drug Repositioning
- Drugs, Investigational -- chemistry
- Human Umbilical Vein Endothelial Cells -- cytology
- Humans
- Mebendazole -- chemistry
- Mice
- Models, Molecular
- Neovascularization, Pathologic
- Pharmaceutical Preparations -- chemistry
- Protein Binding
- Protein Conformation
- Proteins -- chemistry
- Pyrazoles -- metabolism
- Sulfonamides -- metabolism
- United States
- United States Food and Drug Administration
- Vascular Endothelial Growth Factor Receptor-2 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.